Skip to main content

and
  1. Article

    Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study

    Brenda Dorcely, Eliud Sifonte, Collin Popp, Anjana Divakaran, Karin Katz in Endocrine (2022)

  2. No Access

    Article

    Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?

    Identifying the earliest time point on the prediabetic continuum is critical to avoid progressive deterioration in β-cell function. Progressively rising glucose levels even within the “normal range” occur cons...

    Michael Bergman, Ram Jagannathan, Martin Buysschaert, Jose Luis Medina in Endocrine (2017)

  3. No Access

    Article

    Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting

    Ram Jagannathan, Mary Ann Sevick, Huilin Li, Dorothy Fink, Rachel Dankner in Endocrine (2016)

  4. No Access

    Article

    Diabetes as a model for the disparate public response to acute versus chronic diseases

    The public health outcry toward infectious entities appears to dwarf chronic diseases such as diabetes. This disparity is particularly astonishing given the considerable prevalence of diabetes and prediabetes....

    Michael Bergman, Jacqueline Lonier, Dorothy Fink in Endocrine (2016)

  5. No Access

    Article

    Prediabetes and associated disorders

    Prediabetes represents an elevation of plasma glucose above the normal range but below that of clinical diabetes. Prediabetes includes individuals with IFG, IGT, IFG with IGT and elevated HbA1c levels. Insulin...

    Martin Buysschaert, José Luís Medina, Michael Bergman, Avni Shah in Endocrine (2015)

  6. No Access

    Article

    Inadequacies of current approaches to prediabetes and diabetes prevention

    In view of the global shift from communicable to chronic, non-communicable diseases including obesity, prediabetes, and type 2 diabetes mellitus, the increasing prevalence of the latter creates a considerable ...

    Michael Bergman in Endocrine (2013)

  7. No Access

    Article

    Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches

    Diagnosis of dysglycemic states is likely delayed as current diagnostic criteria apply absolute threshold values to a process that is continuous. The importance of this relates to forestalling opportunities fo...

    Michael Bergman, Rachel Dankner, Jesse Roth, K. M. Venkat Narayan in Endocrine (2013)

  8. No Access

    Article

    Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus

    Type 2 diabetes and other non-communicable diseases (NCD) are a growing public health challenge globally. An estimated 285 million people, corresponding to 6.4 % of the world’s adult population has diabetes. T...

    Michael Bergman in Endocrine (2013)